Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study
Resource Type
Article
Authors
Lataillade, Max ; Lalezari, Jacob P ; Kozal, Michael ; Aberg, Judith A ; Pialoux, Gilles ; Cahn, Pedro ; Thompson, Melanie ; Molina, Jean-Michel ; Moreno, Santiago ; Grinsztejn, Beatriz ; Diaz, Ricardo S ; Castagna, Antonella ; Kumar, Princy N ; Latiff, Gulam H ; De Jesus, Edwin ; Wang, Marcia ; Chabria, Shiven ; Gartland, Margaret ; Pierce, Amy ; Ackerman, Peter ; Llamoso, Cyril
Source
In The Lancet HIV November 2020 7(11):e740-e751
Subject
Primary Research Articles
Language
ISSN
2352-3018